Lecture 3: ASD Flashcards

1
Q

Autism Spectrum Disorder

*A neurodevelopmental syndrome
representing a spectrum of impairments
rather than discrete disorders

Definition and prevalence

A
Definition and prevalence
• Persistent deficits in social communication 
  and social interactions
• Pattern of restricted and repetitive 
  behaviors
• Impairment in multiple settings socials, 
  educational, occupational functioning 
• Onset in early childhood (mean: 66.36 
  months; age 5)
•	~5 times more often in boys than girls 
•	1 in 68 children, USA
•	Prevalence varies cross-culturally

*Boys > Girls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Comorbidity (associated deficits)

ASD

A
• Children with ASD often present with:
o	Intellectual impairment
o	Language impairment
o	Motor deficits
o	Poor adaptive behavior
o	Medical problems
• Children with ASD often have behavioural 
  problems:
o	Aggressiveness
o	Hyperactivity
o	Impulsivity
o	Attention problems
o	Self-injurious behavior 

Comorbidity
• In general, ASD follows a continuous
course but depending on intelligence level
and language skills, developmental gains
are possible during school-age years
• A minority of individuals with ASD live and
work independently
• Early intervention and structured
behavioural support programs can enhance
the functioning of children in later life; ASD
individuals with the higher language and
intellectual abilities have a greater
likelihood of living independently.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Savants

A

• In rare cases children with ASD can have
exceptional skills known as savant talents:
o Music
o Memory
o Mathematics
o Specific knowledge
o Art
• Rare cases (one in ten individuals with ASD)

Reading:
- Savant skills: (a) are accompanied with at
least an average level intelligence; (b) skills
are similar to those without ASD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Genetics
*Genes play a major role in the
development of ASD

Family and twin studies

A

Family and twin studies
• Having at least one older sibling with ASD
increases the risk of the disorder in
younger siblings by 18.7%
o Considerably higher than previous
estimates of 3% to 10%
o Higher risk in younger male siblings
relative to female (26% vs 9%)
• Risk of ASD 33% to 50% if two or more
siblings have the disorder
• First degree relatives of ASD individuals
have increased behavioural and cognitive
symptoms (i.e., social communication
problems)
• Higher rates for monozygotic (identical)
than dizygotic twins (i.e., heritability
estimates; 0.64- 0.91 vs. 0.18-0.34)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Linkage studies and candidate genes

Majority of cases are…
Do they have an identifiable genetic condition?
Gene variation?

A

Linkage studies and candidate genes
• Majority of cases of ASD are idiopathic
(spontaneous with an unknown cause)
• ~10% have an identifiable genetic condition
• Fragile X syndrome
• Tuberous sclerosis
• Prader Willi syndrome

Genetics
• Substantial genetic heterogeneity in ASD
o Genes may be different for every individual
o May involve many genes (10-100s)
o May interact with environmental factors
• Chromosomal abnormalities involving
nearly every chromosome have been linked
to ASD
o Chromosomal duplications
o Inversions
o Terminal and interstitial deletions
o Translocations
• Over 1,000 genes have been linked to ASD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Linkage and Genome Studies

Genetics (GABA)

A
Genetics (GABA)
• Variants of the GABRA4 gene 
  (chromosome 4) and GABRB3 gene 
  (chromosome 15) 
• These genes encode a protein that is part 
  of the GABA receptor which plays an 
  important role in neuronal inhibition.
• GABRB3 gene is a focus of ASD research 
  because individuals with Prader-Willi 
  syndrome and Angelman’s syndrome 
  (caused by abnormalities of chromosome 
  15) tend to have coexisting ASD.

*For Autism they tend to say coexisting
instead of comorbidity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Linkage and Genome Studies

Oxytocin receptor gene (OXTR)

A

Oxytocin receptor gene (OXTR)
• OXTR gene (chromosome 20) is implicated
in the production of oxytocin (love drug) that
is involved in social bonding and affiliative
behaviour.
• It has been studied in relation to ASD due
to their deficits in social bonding and
affiliation deficits.
• Four polymorphisms in OXTR gene are
associated with differences in amygdala
volume and white matter connectivity in
ASD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Linkage and Genome Studies

RELN gene

A

RELN gene
• RELN gene is located on chromosome 7
and provides instruction for the production
of reelin. It is thought to play a critical role in
cell migration and neuroplasticity during
development.
• Polymorphisms of RELN gene (rs362691)
are associated with increased risk of ASD.
•.More than 40% reduction of reelin protein
in ASD postmortem samples.
• A single mutation of the RELN gene can
result in reduced reelin production, cellular
function and neuroplasticity during
development.
• RELN mutations are 4x more likely in males
than females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Linkage and Genome Studies

SHANK3 gene

A

SHANK3 gene
• Located on chromosome 22 and provides
instructions to make the protein proline-rich
synapse-associated protein that plays a
critical role in the formation of dendritic
spines and in synaptic connections.
• Mutations of SHANK3 gene linked to ASD
(mixed)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Linkage and Genome Studies

Other genes

A
Other genes
• Serotonin transporter gene (SLC6A4)
• N-methyl-D-aspartate receptor gene  
  (NMDA, GRIN2B)
• Arginine vasopressin receptor 1A gene 
  (AVPR1A)
• Engrailed homeobox 2 (EN2)
• Integrin, beta 3 (platelet glycoprotein IIIa, 
  antigen CD61; ITGB3)
• Met proto-oncogene (hepatocyte growth 
  factor receptor; MET)
• Contactin-associated protein-like 2 
  (CNTCAP2)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Environment

A

• Research in its infancy, speculate stress
and other factors influence cellular
functioning (epigenetics; how environment
influences gene expression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Structural findings

A

• Differences in total brain volume, volume of
specific structures, gray and white matter,
cortical thickness/thinning, and more
connectivity between structures and brain
regions:
o ~20% of individuals with ASD have
unusually large head circumference
o ~15% of individuals with ASD have
unusually small head circumference
o Enlarged brain volume (macroencephaly is
more common in low functioning ASD and
in younger but not older children)
o Brain volume normal at birth; however, by
ages 2-4 years, 90% of boys with ASD have
greater than average brain size
o Concomitant regional volume differences in
the frontal and temporal (increase) lobes
o Reduced cortical thickness in temporal
cortex
o Increased cortical thickness in frontal
cortex
o Fewer neurons
o Smaller neurons
o Smaller receptor densities in cerebellum,
frontal and temporal cortex
- Smaller subcortical volumes
- Pallidum
- Putamen
- Amygdala
- Nucleus accumbens
- Corpus callosum
o Enlargement of the caudate nucleus
(enlargement is associated with increased
symptom severity and restrictive/repetitive
behaviours)

*Structural cellular differences believed to be
caused by problems with neural migration
and connectivity in individuals with ASD
*Abnormal brain development in ASD within
the frontal, parietal, and subcortical
structures. These are involved in language,
social perception, self-referential, and self-
regulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

White matter

A

• ASD is associated with gray matter
reductions, excess white matter, and
widespread compromised integrity of white
matter tracts throughout the brain.
• E.g., abnormalities of white matter tracts
connecting the right amygdala to the right
cortex (is associated with the severity of
emotional recognition deficits in ASD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Interpretation of results

A

• Not all studies find morphological
differences in ASD
• Most of the identified morphological
differences are not unique to ASD
o E.g., cortical thinning, reduced gray/white
matter, impaired white matter integrity,
enlarged caudate have been seen in
schizophrenia, anxiety disorders, OCD,
ADHD, bipolar disorder, and Tourettes.
o Support vector models can be used to
discriminate morphological differences
between ASD and other disorders or
controls (e.g., in infants at risk of ASD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ASD brain bank

A

• Neuroimaging studies lack the resolution
needed to examine cellular and molecular
changes associated with ASD. Postmortems
of high-quality ASD brain tissue is needed.
• To support the collection of high-quality
brain tissue, ASD brain back was developed - a privately funded network of brain tissue
collection
• Strict procedures for collecting, preparing,
and preserving human brain donations
• Autism Brain Net (autismbrainnet.org)

*Structural findings are correlational! We don’t
know whether morphological differences
cause symptoms or vice versa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Functional findings (rCBF)

A

• Initially ASD individuals show decreased
rCBF in frontal regions
• 76% of ASD children show increased rCBF
in the temporal lobes (language region is
impacted!)
• Normal regional cerebral blood flow values
are attainted by age 7
• Reduced blood flow in prefrontal regions

*Reduced blood flow in prefrontal and
language related regions begins at an early
age and impairs normal development of
language. Social communication deficits
characteristics of ASD have also been linked
to differential brain activation patterns
observed when ASD individuals are
presented with facial stimuli.

Reading:
• High functioning ASD during emotion
recognition tasks showed reduced rCBF in
the inferior frontal regions and higher rCBF
in the anterior cingulate and thalamus.
These findings correlated with poor
neuropsychological task performance.

17
Q

Glucose metabolism findings

A
Glucose metabolism findings
• Elevated glucose metabolism in 
  widespread regions of the brain
• Lower glucose metabolism in the medial 
  frontal lobes (controversial) 
• Inconsistent patterns of glucose 
  metabolism may reflect the heterogeneity 
  of ASD?

Reading:
Example conflicting findings:
o Increased glucose metabolism (activity) in
the occipital and parietal regions in
individuals with ASD relative to controls
whilst at rest and during attentional tasks.
o Reduced glucose metabolism in the
cerebellum, temporal, frontal, and occipital
regions

18
Q

fMRI

A

fMRI
• Greater activation of the cerebellum during
a motor task
• Reduced activation of the cerebellum
during an attention task
• These differential functional findings
support structural findings of decreased
cerebellum volume in participants in ASD
• Abnormal activation in regions involved in
emotional face processing and social
cognition (both increased and decreased
activation) in:
o Frontal cortex
o Amygdala
o Insula
o Other limbic structures
• Mixed findings about white matter
connectivity between limbic, frontal, and
temporal regions (overactivity, interactivity,
or a combination)

19
Q

Functional Findings Summary:

A

Functional Findings Summary:
• Functional neuroimaging studies have found
evidence of both decreased and increased
glucose metabolism and blood flow in ASD
relative to controls.
• Most common functional disturbances occur
in the limbic regions and projecting cortical
pathways to frontal and temporal regions.
• There are significant discrepancies and
conflicting results across studies! These may
reflect heterogeneity of ASD of
methodological/procedural variations across
studies.

20
Q

Additional Theories

Prenatal factors, viruses, vaccines, dietary deficiencies

Other theories

A

Prenatal factors, viruses, vaccines, dietary deficiencies

• Prenatal Factors:
o Pregnancy complications (maternal
melatonin levels, vaginal infection, or
uterine bleeding)
o Exposure to viruses during pregnancy
(cytomegalovirus, viral encephalitis, viral
meningitis)

• Postnatal Factors:
o Vaccinations (measles mumps rubella, or
MMR)
o No association between MMR vaccination
and ASD!

Others
• Immunological abnormalities (decreased T
and B cells, macrophages, and natural killer
cells)
• Gut microbiota and inflammation
• Medications used to control infectious
fevers in pregnancy or young children (e.g.,
acetaminophen)
• Dietary factors (metabolic and nutritional
deficiencies, phenylketonuria, choline, and
creatine; some suggest metabolic indices
may serve as biomarkers)

*None of these factors are considered causal
or diagnostic biomarkers

21
Q

Pharmacological interventions

A
• There is no FDA treatment approved 
  which targets the core symptoms of ASD
• Two antipsychotic medications 
  (aripiprazole and risperidone) can be used 
  to treat non-core ASD symptoms:
o	Irritability and aggressive behavior
o	Agitation
o	Hyperactivity
o	Stereotypies (repetitive behavior)
o	Self-injurious behavior
o	Their effectiveness varies!
22
Q

Other medications investigated

A
Other medications investigated 
*With varying effectiveness
•	Anticonvulsants
•	α-agonists
•	Norepinephrine reuptake inhibitors
•	Lithium
•	GABA agonists
•	Buspirone
•	Oxytocin
• Antidepressants are commonly used to 
  treat ASD but there are no empirical studies 
  which support their effectiveness
• Common drug combinations:
• Stimulants and antidepressants (38%)
• Stimulants and antipsychotics (28%)
• Antipsychotics and antidepressants (20%)
• Stimulants, antipsychotics, and 
  antidepressants (18%)
23
Q

Methylphenidate

A

Methylphenidate
• Improve attention skills in some children
with ASD
• Short-term use is associated with improved
symptoms of hyperactivity and inattention
in children which tolerate methylphenidate.
Improvement is not found in social
interaction, repetitive behaviors.

24
Q

Alternative Treatments

A

Alternative Treatments
• 30% of ASD individuals are being treated
by alternative remedies such as nutritional
supplements, chelating agents, hormone
therapy, and restrictive diets but their
effectiveness is not supported by empirical
evidence.
• Behavioural interventions that target
communication and social behaviours while
reducing problem behaviour have strong
empirical support and are considered
primary and effective treatment for ASD
symptoms.

25
Q

Summary: ASD

A

Summary: ASD
• Research supports the role of genetic
factors in the development of ASD but other
prenatal factors may be involved.
• Structural findings have been mixed but
indicate morphological differences in the
cerebellum, subcortical, temporal, and
frontal regions; may not be unique to ASD.
• Functional studies implicate glucose, blood
flow, and white matter connectivity
differences in ASD but results are highly
variables.
• Functional differences may reflect
heterogeneity of ASD or methodological
differences across studies.
• Pharmacological interventions play a
secondary role to behavioural interventions
in the treatment of ASD.
• Whilst genetic/environmental theories exist
regarding the aetiology of ASD, the
underlying cause remains unclear.